Kingsview Wealth Management LLC bought a new stake in shares of Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 4,945 shares of the technology company's stock, valued at approximately $456,000.
A number of other institutional investors have also recently modified their holdings of CLS. Vaughan Nelson Investment Management L.P. bought a new stake in shares of Celestica during the 3rd quarter valued at $61,210,000. Whale Rock Capital Management LLC raised its holdings in shares of Celestica by 13.0% during the 3rd quarter. Whale Rock Capital Management LLC now owns 8,467,244 shares of the technology company's stock worth $432,846,000 after buying an additional 975,163 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Celestica by 38.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,084,722 shares of the technology company's stock worth $55,451,000 after buying an additional 301,563 shares in the last quarter. Natixis Advisors LLC raised its holdings in shares of Celestica by 1,697.3% during the 3rd quarter. Natixis Advisors LLC now owns 233,485 shares of the technology company's stock worth $11,936,000 after buying an additional 220,494 shares in the last quarter. Finally, Broad Peak Investment Advisers Pte Ltd raised its holdings in shares of Celestica by 53.8% during the 3rd quarter. Broad Peak Investment Advisers Pte Ltd now owns 524,245 shares of the technology company's stock worth $26,799,000 after buying an additional 183,300 shares in the last quarter. 67.38% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on CLS shares. Cibc World Mkts raised Celestica from a "hold" rating to a "strong-buy" rating in a report on Friday, January 31st. Royal Bank of Canada boosted their price target on Celestica from $115.00 to $140.00 and gave the stock an "outperform" rating in a report on Friday, January 31st. Stifel Nicolaus started coverage on Celestica in a report on Tuesday, February 4th. They set a "buy" rating and a $140.00 price target for the company. Canaccord Genuity Group upped their target price on Celestica from $77.00 to $110.00 and gave the stock a "buy" rating in a report on Friday, December 20th. Finally, Barclays upped their target price on Celestica from $139.00 to $157.00 and gave the stock an "overweight" rating in a report on Thursday. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $104.91.
View Our Latest Stock Report on CLS
Celestica Trading Up 1.8 %
Shares of NYSE CLS traded up $2.38 during trading on Monday, reaching $132.16. The company had a trading volume of 2,707,072 shares, compared to its average volume of 5,877,522. The company's fifty day moving average price is $107.98 and its 200-day moving average price is $78.37. Celestica Inc. has a 12 month low of $36.11 and a 12 month high of $144.27. The stock has a market cap of $15.38 billion, a P/E ratio of 35.34 and a beta of 2.27. The company has a quick ratio of 0.87, a current ratio of 1.47 and a debt-to-equity ratio of 0.49.
Insider Buying and Selling at Celestica
In other Celestica news, President Todd C. Cooper sold 65,000 shares of the stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $129.78, for a total value of $8,435,700.00. Following the transaction, the president now owns 110,426 shares in the company, valued at approximately $14,331,086.28. This represents a 37.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Yann L. Etienvre sold 9,181 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $127.54, for a total value of $1,170,944.74. Following the completion of the transaction, the insider now owns 83,179 shares in the company, valued at approximately $10,608,649.66. The trade was a 9.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 959,381 shares of company stock worth $119,142,019. Insiders own 1.00% of the company's stock.
Celestica Company Profile
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
See Also

Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.